DRUG REFRACTORY PAROXYSMAL ATRIAL FIBRILLATION
Clinical trials for DRUG REFRACTORY PAROXYSMAL ATRIAL FIBRILLATION explained in plain language.
Never miss a new study
Get alerted when new DRUG REFRACTORY PAROXYSMAL ATRIAL FIBRILLATION trials appear
Sign up with your email to follow new studies for DRUG REFRACTORY PAROXYSMAL ATRIAL FIBRILLATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart rhythm breakthrough? new ablation device shows promise for AFib
Disease control CompletedThis completed study tested a new catheter and generator system designed to treat paroxysmal atrial fibrillation (AFib) — a common heart rhythm problem. The device uses pulsed field ablation (PFA) to target and destroy tiny areas of heart tissue causing the irregular rhythm. 188 …
Matched conditions: DRUG REFRACTORY PAROXYSMAL ATRIAL FIBRILLATION
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New heart catheter shows promise for AFib patients
Disease control CompletedThis study tested a special catheter system to treat people with a type of irregular heartbeat called paroxysmal atrial fibrillation (PAF) that didn't get better with medication. The treatment uses heat energy to isolate the veins that trigger the abnormal rhythm. The study inclu…
Matched conditions: DRUG REFRACTORY PAROXYSMAL ATRIAL FIBRILLATION
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC